Clinical Trial Update: Efficacy and Safety of XG-104 for the Treatment of Dry Eye [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating XG-104 for dry eye disease has completed, with the update detailing efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• XG-104

Snippet

Sponsor: Xigen SA | Conditions: Dry Eye | Phase 2 | Status: COMPLETED